Tag | Content |
---|
EnhancerAtlas ID | HS191-01901 |
Organism | Homo sapiens |
Tissue/cell | Trophoblast |
Coordinate | chr1:109189290-109190250 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF5 | MA0599.1 | chr1:109189406-109189416 | GCCCCGCCCC | + | 6.02 | NKX2-5 | MA0063.2 | chr1:109190037-109190047 | ACCACTTGAG | + | 6.02 | ZNF263 | MA0528.1 | chr1:109190153-109190174 | GGAGGAGGTGAGGTGGGAGGA | + | 6.46 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_22936 | chr1:109185997-109191738 | CD8_primiary |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 109189516 | 109189718 | chr1 | 109189299 | 109190000 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I108643 | chr1 | 109186465 | 109191543 |
|
Enhancer Sequence | TCGCACCATC CCCTTAGTGC TGTTCTCGTG ACAGAGTCCG CCCAAGACCT GCTTAAACGT 60 GTTCAGCACC ACCCCTCGCT CCGCCTTGCT CCTGTTCCCA CCATGTGAGA TGCCTCGCCC 120 CGCCCCAACC CTTTGCCTTC TGCCATTACT GGAAGTTTCC TGAGGCCTCC CCAGAAGCAG 180 AAGCTGCTAT GCTTCCTGTA CACTCTGTGG AACCATGAGC CAATAAACCT CTTTATTACC 240 CAGTCTCTGC TATTTCTTTA CAGCAATGCA AGAACAGACT AATATATCAG CTTCCCTTTG 300 TGTGGCCTGA AGACCACATT CTGATCAACA GGAAGTAAGC AGTCGTGTTG CGTAACAACC 360 CACAGCAAGC TTTACCAGAC AGCTTGTGTG TGCCCTTTGT CCCTTCTCTT CTTTCTGCTG 420 TTTCAGAATA TGAAAGTAGT AGCCAGAGCT CAAATCTCTC TCTCTGTCCC TGGATGGCAT 480 ACTAAGTAGC CACAACATGC AAGATGGACG TCTGGGTCCC AAAAGTGGCA GAGCTCCCAT 540 GCCTGGGGCT TACCTCTGGA CTCCTGTGCC TAAGAAATGC CTCTCATTTA AACTACTGTT 600 TTCCCCCATG AGGTGAAGCT ATGTTTCTTT CTCCCATTAG TACTACCACC CCAATTCCAA 660 CCAGAGAAGT ACTACCACCC CAATTCCATC CTCAGAAGAG GGTGCTCAAA AAACAATCCC 720 AGCACTTTGG GAAGCTGAGG CAGGAGGACC ACTTGAGCCC AGAAGTTCAA GACCAGTCTG 780 GGCAACATAG TGAGACCCTA TCTCTACAAA TTTTTAATTA GCTGGGCATG GTGGTACATG 840 CCAGTAGTTC AAGCTACTGG TGGGGAGGAG GTGAGGTGGG AGGATTATTT TAGCCCAGAG 900 GCTGAGGCTA CAATGAGCCA TGATTGTGCC ACTGCACTCC AGCCTGGGTA ACAGAACAAG 960
|